Month: November 2020

No Picture
Trading Ideas

Compass Therapeutics IPO Set for $50 Million Nasdaq Offering

November 11, 2020 admin Comments Off on Compass Therapeutics IPO Set for $50 Million Nasdaq Offering

The Compass Therapeutics IPO is set to hit the market. The company saw successful preclinical trials and hopes to have its products approved by 2022. Now, investors are interested in Compass Therapeutics stock.
But is Compass Therapeutics a good investment? Here’s what we know…
Compass Therapeutics IPO: The Business

Thomas Schuetz, MD, PhD co-founded Compass Therapeutics in 2014. At the time, he was a venture partner at OrbiMed, Compass’ largest shareholder. The company is a clinical-stage biopharmaceutical company. Compass’ goal is to support the role of the immune system using anti-body based therapies to fight cancer. It claims its approach can be used …read more […]

No Picture
Trading Ideas

Stock Market Crash History, Causes and More

November 11, 2020 admin Comments Off on Stock Market Crash History, Causes and More

While the 1929 stock market crash did not directly cause the Great Depression, it was the beginning of a downward spiral for the United States economy. Capitalism revolves around an economic cycle of expansion and contraction. This means that the stock market can increase in value for a while, but a decline will always occur at some point.

What Is a Stock Market Crash?
A stock market crash is when stock prices drastically decline in a short amount of time. When this happens, investors lose a huge amount of wealth on paper. Unfortunately, a stock market crash can lead to panic selling. …read more […]

No Picture
Trading Ideas

Is Five Prime Stock a Buy Right Now? This Is What You Need To Know

November 11, 2020 admin Comments Off on Is Five Prime Stock a Buy Right Now? This Is What You Need To Know

Change is in the air. A new President-elect and the possibility of an end to the pandemic. Some things, however, will always stay the same.Like small cap biotech stocks skyrocketing following the announcement of positive clinical trial results. Case in point: Five Prime Therapeutics (FPRX) shares took off in Wednesday’s trading as much as 349%, after the company disclosed that bemarituzumab, its stomach cancer drug candidate, beat the placebo in a midstage trial.Specifically, in the Phase 2 study (FIGHT) assessing a blend of bemarituzumab and chemo regimen mFOLFOX6 in patients with fibroblast growth factor receptor 2b-positive (FGFR2b+), non HER2-positive (non …read more […]

No Picture
Trading Ideas

Moderna Bears Face Possible Squeeze on Covid Vaccine Results

November 11, 2020 admin Comments Off on Moderna Bears Face Possible Squeeze on Covid Vaccine Results

(Bloomberg) — Bearish investors are holding on to their short bets on Moderna Inc. even as the biotech’s market value swelled by more than $25 billion this year on optimism its experimental messenger-RNA vaccine will play a part in tamping down the pandemic.Options data suggest the stock is ready for another double-digit swing over the next few weeks and with S3 Partners data showing about $1.84 billion shares shorted, bears might face fresh pain or finally claw back some losses.Moderna “was and is now a short squeeze candidate,” Ihor Dusaniwsky, S3’s managing director of predictive analytics, said in an interview.The …read more […]

No Picture
Trading Ideas

Small-Cap Biotech Surges Almost 350% on Cancer-Drug Trial Data

November 11, 2020 admin Comments Off on Small-Cap Biotech Surges Almost 350% on Cancer-Drug Trial Data

(Bloomberg) — Small-cap drug developer Five Prime Therapeutics Inc. is on track to post one of this year’s biggest daily stock moves after reporting promising data from a mid-stage cancer study.The South San Francisco, California-based biotech firm skyrocketed as much as 349% after a combination of its drug and chemotherapy helped some patients keep their stomach cancer at bay for longer than those receiving just chemotherapy. Should this rally hold, it would be the third biggest single-day move on the New York Stock Exchange and Nasdaq Exchange, according to data compiled by Bloomberg.Its stock-surge trails a pair of micro-caps with …read more […]